Profile data is unavailable for this security.
About the company
OK Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides home medical blood glucose meters and disposable blood glucose test strips. Its products are mainly catering to diabetes patients, as well as doctors or nurses in hospitals and clinics for monitoring blood glucose levels. The Company distributes its products in Americas, Taiwan and other Asian markets.
- Revenue in TWD (TTM)1.64bn
- Net income in TWD68.75m
- Incorporated2004
- Employees62.00
- LocationOK Biotech Co LtdNo.91, Section 2, Gongdao 5th RoadHSINCHU 300TaiwanTWN
- Phone+886 35160258
- Fax+886 35160028
- Websitehttps://www.okbiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OK Biotech Co Ltd | 1.64bn | 68.75m | 2.09bn | 62.00 | 31.15 | 0.8265 | 12.23 | 1.28 | 0.4639 | 0.4639 | 11.32 | 17.48 | 0.4478 | 2.62 | 2.98 | -- | 2.29 | 2.73 | 2.90 | 3.60 | 27.01 | 18.75 | 5.11 | 5.56 | 1.17 | 3.92 | 0.3009 | 111.05 | 40.11 | 6.11 | 3,087.75 | -5.66 | 37.07 | -24.66 |
| Wellell Inc | 2.39bn | 138.72m | 2.31bn | 535.00 | 16.75 | 0.9462 | 9.57 | 0.9655 | 1.37 | 1.37 | 23.60 | 24.20 | 0.7533 | 2.78 | 6.25 | -- | 4.40 | 4.07 | 5.47 | 5.35 | 46.15 | 42.35 | 5.85 | 5.30 | 1.99 | -- | 0.1184 | 56.36 | -9.84 | 3.23 | -24.27 | 5.56 | 13.42 | 12.20 |
Data as of Mar 03 2026. Currency figures normalised to OK Biotech Co Ltd's reporting currency: Taiwan Dollar TWD
0.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 471.15k | 0.33% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 40.01k | 0.03% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 1.00k | 0.00% |
| DFA Australia Ltd.as of 30 Nov 2025 | 861.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
